Are triglycerides bad
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Are Triglycerides Bad? An Analysis of Their Impact on Cardiovascular Health
Elevated Triglycerides and Cardiovascular Disease Risk
Triglycerides and Cardiovascular Disease (CVD)
Elevated triglyceride levels have long been associated with an increased risk of cardiovascular disease (CVD). This relationship has been debated for decades, with some arguing that triglycerides are a direct cause of CVD, while others view them as a biomarker indicating other underlying issues. Recent insights have highlighted the atherogenic potential of triglyceride-rich lipoproteins (TRLs), such as chylomicrons and very low-density lipoproteins (VLDL), which contribute to the development of atherosclerosis.
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease (ASCVD)
New epidemiological and genetic studies have reinforced the notion that triglyceride-rich lipoproteins are strong, independent predictors of atherosclerotic cardiovascular disease (ASCVD) and all-cause mortality. High levels of these lipoproteins are associated with increased risks of myocardial infarction, ischemic heart disease, ischemic stroke, and overall mortality. Genetic evidence further supports the causal relationship between elevated triglyceride-rich lipoproteins and ASCVD, suggesting that these lipoproteins contribute to low-grade inflammation, a key factor in atherosclerosis.
Triglycerides in Type 2 Diabetes Mellitus (T2DM)
Triglycerides as a Risk Factor in T2DM
In individuals with type 2 diabetes mellitus (T2DM), the relationship between triglycerides and cardiovascular events is complex. While higher triglyceride levels are generally associated with increased cardiovascular risk, they do not serve as an independent marker for cardiovascular events in T2DM patients. However, elevated triglyceride levels still tend to correlate with higher risks of cardiovascular diseases in this population.
Triglyceride Lowering and Cardiovascular Outcomes
The impact of lowering triglyceride levels on cardiovascular outcomes remains uncertain. For instance, a study on the drug pemafibrate, which effectively reduces triglyceride levels, found no significant reduction in cardiovascular events among patients with T2DM and mild-to-moderate hypertriglyceridemia. Despite lowering triglyceride and other lipid levels, pemafibrate did not lead to a lower incidence of cardiovascular events compared to a placebo.
Triglycerides and Ischemic Heart Disease (IHD)
Long-Term Risk of IHD
Long-term studies have shown that high fasting triglyceride levels are a significant risk factor for ischemic heart disease (IHD). In a cohort of middle-aged and elderly men, higher triglyceride levels were associated with a greater incidence of IHD, independent of other risk factors such as HDL cholesterol levels. This suggests that triglycerides play a crucial role in the development of IHD, even when other lipid levels are controlled.
Conclusion
In summary, elevated triglyceride levels are associated with an increased risk of cardiovascular diseases, including ASCVD and IHD. While the exact role of triglycerides as a direct cause versus a biomarker of risk continues to be explored, current evidence strongly supports their contribution to cardiovascular risk. This is particularly evident in the context of triglyceride-rich lipoproteins and their role in inflammation and atherosclerosis. For individuals with T2DM, managing triglyceride levels remains important, although it may not independently predict cardiovascular events. Overall, maintaining healthy triglyceride levels is crucial for reducing cardiovascular risk and improving long-term health outcomes.
Sources and full results
Most relevant research papers on this topic